Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Michael E Wechsler"'
Autor:
Namrata Pandit-Abid, Benjamin Ortiz, Nadia Daizadeh, Jorge Maspero, Michael E. Wechsler, Elizabeth Laws, David J. Lederer, Leda Mannent, Lawrence Sher, Marcella Ruddy, Klaus F. Rabe, Megan Hardin, Xuezhou Mao
Publikováno v:
Chest. 160:A1882-A1884
Autor:
Tobias Welte, Kinga Sałapa, Michael E. Wechsler, P. Kaur, Gun Almqvist, Tor Skärby, Gene L. Colice, A. Menzies Gow, Janet M. Griffiths, Christopher E. Brightling, Åsa Hellqvist, Stephanie Korn, Piotr Kuna
Publikováno v:
TP10. TP010 CLINICAL AND POPULATION-LEVEL STUDIES OF ASTHMA.
Autor:
Nicolas Fandino, Gheorghe Doros, Wilson D. Pace, Anne L. Fuhlbrigge, Nicole L. Grossman, Michael E. Wechsler, Elliot Israel, Barbara P. Yawn
Publikováno v:
Journal of Asthma. 56:704-710
Exacerbations account for much of the morbidity in asthma. In a large intervention study, we sought to test the hypothesis that a Black adult exacerbation-prone phenotype - a group of Black people with asthma who are at high risk of repeat exacerbati
Autor:
Leda Mannent, U Kapoor, Michael E. Wechsler, Ian D. Pavord, Christian Domingo, Elizabeth Laws, Henrik Watz, Marcella Ruddy, Faisal A. Khokhar, Arnaud Bourdin, Megan Hardin, Xuezhou Mao, Alberto Papi, Nikhil Amin
Publikováno v:
Disease modulation within severe asthma.
Introduction and Objectives Dupilumab, a fully human monocolonal antibody, blocks the shared receptor component for interleukin (IL)–4 and IL–13, key and central drivers of type 2 inflammation in multiple diseases. The efficacy and safety up to 5
Autor:
Teresa Piechowiak, Primal Kaur, Esther Garcia Gil, Gun Almqvist, Tor Skärby, Janet M. Griffiths, Karin Bowen, May Mo, Michael E. Wechsler, Gene L. Colice, Åsa Hellqvist
Publikováno v:
Respiratory Research
Respiratory Research, Vol 21, Iss 1, Pp 1-10 (2020)
Respiratory Research, Vol 21, Iss 1, Pp 1-10 (2020)
Background Many patients with severe asthma continue to experience asthma symptoms and exacerbations despite standard-of-care treatment. A substantial proportion of these patients require long-term treatment with oral corticosteroids (OCS), often at
Autor:
Mary Gill, Yeshai T. Dollin, Vamsi P. Guntur, Joshua L. Denson, Christena A. Kolakowski, Michael E. Wechsler, Laurie A. Manka, Ryan M. Dunn, Matthew Strand
Publikováno v:
The journal of allergy and clinical immunology. In practice. 9(3)
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a vasculitis associated with significant morbidity and mortality that has historically been treated with systemic corticosteroids and immunosuppressants. The IL-5 antagonist mepolizum
Autor:
Juliana Durack, Laura S. Christian, Snehal Nariya, Jeanmarie Gonzalez, Nirav R. Bhakta, K. Mark Ansel, Avraham Beigelman, Mario Castro, Anne-Marie Dyer, Elliot Israel, Monica Kraft, Richard J. Martin, David T. Mauger, Stephen P. Peters, Sharon R. Rosenberg, Christine A. Sorkness, Michael E. Wechsler, Sally E. Wenzel, Steven R. White, Susan V. Lynch, Homer A. Boushey, Yvonne J. Huang
Publikováno v:
J Allergy Clin Immunol
Background Whether microbiome characteristics of induced sputum or oral samples demonstrate unique relationships to features of atopy or mild asthma in adults is unknown. Objective We sought to determine sputum and oral microbiota relationships to cl
Autor:
Jonathan Steinfeld, Jane H Bentley, David Jayne, Namhee Kwon, B. Hellmich, Benjamin Terrier, Michael E. Wechsler, Steven W. Yancey
Publikováno v:
Annals of Allergy, Asthma & Immunology. 127:S7
Autor:
Juan Carlos Cardet, Xiaofeng Jiang, Quan Lu, Norma Gerard, Kristen McIntire, Homer A. Boushey, Mario Castro, Vernon M. Chinchilli, Christopher D. Codispoti, Anne-Marie Dyer, Fernando Holguin, Monica Kraft, Stephen Lazarus, Robert F. Lemanske, Njira Lugogo, Dave Mauger, Wendy C. Moore, James Moy, Victor E. Ortega, Stephen P. Peters, Lewis J. Smith, Julian Solway, Christine A. Sorkness, Kaharu Sumino, Michael E. Wechsler, Sally Wenzel, Elliot Israel
Background Loss of bronchoprotection (LOBP) with a regularly used long-acting β2-adrenergic receptor agonist (LABA) is well documented. LOBP has been attributed to β2-adrenergic receptor (B2AR) downregulation, a process requiring farnesylation, whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c67563a07a2796a5482f8f892fcbd62
https://europepmc.org/articles/PMC6950766/
https://europepmc.org/articles/PMC6950766/
Autor:
Victoria E. Forth, Ku-Lang Chang, Wilfredo Morales-Cosme, Maureen Fagan, Cynthia S. Rand, Wilson D. Pace, Hazel Tapp, Michael E. Wechsler, Andrea J. Apter, Anne L. Fuhlbrigge, Paulina Arias Hernandez, Kartik Shenoy, Joel Shields, Michelle L. Hernandez, Elliot Israel, Paula J. Busse, David C. Kaelber, Nancy E. Maher, Laura P. Hurley, Tamera Coyne-Beasley, Thomas B. Casale, Isaretta L. Riley, Sylvette Nazario, Mary White, Lilin She, Jacqueline Rodriguez-Louis, Juan Carlos Cardet, Paul M. Stranges, Barbara M Kaplan, Geoffrey Chupp, Ahmet Baydur, Magdalena Pasarica, Juan P. Wisnivesky, Frank W. Rockhold, Brian K. Manning, Barbara P. Yawn, Jennifer Trevor, Victor Pinto-Plata, Jennifer K. Carroll, M. Diane McKee, Rafael Calderon-Candelario
Publikováno v:
Contemporary clinical trials
Background Asthma prevalence, morbidity, and mortality disproportionately impact African American/Black (AA/B) and Hispanic/Latinx (H/L) communities. Adherence to daily inhaled corticosteroid (ICS), recommended by asthma guidelines in all but the mil